Products for Research Use Only
RegisterLogin

Sugemalimab

CAT: 0804-HY-P99114-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99114-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb) . Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research[1].
CAS Number
2256084-03-2
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sugemalimab.html
Purity
98.3
Solubility
H2O
Smiles
[Sugemalimab]
Molecular Weight
(143.33 kDa)
References & Citations
[1]Dhillon S, et al. Sugemalimab: First Approval. Drugs. 2022 Apr;82 (5) :593-599.|[2]Zhang J, et al. The preclinical characterization of CS1001, an anti-PD-L1 IgG4 monoclonal antibody and its activity beyond T cell regulation. Cancer Research, 2020, 80 (16_Supplement) : 3260-3260.
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T76714-01Sugemalimab
GTR18337564-01Sugemalimab Antibody
WA3577Research Grade Sugemalimab
E55B0445Sugemalimab (Reference antibody)
ICH5278-10mgSugemalimab Biosimilar - Research Grade
A138570Sugemalimab Biosimilar (Monoclonal, IgG4)
21-968Sugemalimab - Research Grade Biosimilar
GTR18697758-01Sugemalimab Human Monoclonal Antibody
GTR18780758-01(Sugemalimab) Biosimilar Reference Antibody
A135046Sugemalimab Biosimilar (Monoclonal, IgG4-lambda)

Popular Products